| 技术与方法 |
|
|
|
|
| 位点特异整合微环DNA的体内制备 |
| 聂永强1, 马海燕1,2, 马晴雯1,2 |
1. 上海交通大学附属儿童医院 上海市儿童医院 上海交通大学医学遗传研究所 上海 200040;
2. 卫生部医学胚胎分子生物学重点实验室暨上海市胚胎与生殖工程重点实验室 上海 200040 |
|
| An in vivo Robust System for Generation of Site-specific Integration Minicircle DNA Vector |
| NIE Yong-qiang1, MA Hai-yan1,2, MA Qing-wen1,2 |
1. Shanghai Institute of Medical Genetics, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai 200040, China;
2. Key Laboratory of Embryo Molecular Biology, Ministry of Health & Shanghai Key Laboratory of Embryo and Reproduction Engineering, Shanghai 200040, China |
[1] Maniar L E G, Maniar J M, Chen Z, et al. Minicircle DNA vectors achieve sustained expression reflected by active chromatin and transcriptional level. Molecular Therapy, 2013, 21(1): 131-138.
[2] Gaspar V, de Melo-Diogo D, Costa E, et al. Minicircle DNA vectors for gene therapy: advances and applications. Expert Opin Biol Ther, 2015, 15(3): 353-379.
[3] Karow M, Calos M P. The therapeutic potential of PhiC31 integrase as a gene therapy system. Expert Opin Biol Ther, 2011, 11(10): 1287-1296.
[4] Chalberg T W, Portlock J L, Olivares E C, et al. Integration specificity of phage phiC31 integrase in the human genome. J Mol Biol, 2006, 357(1): 28-48.
[5] Bigger B W, Tolmachov O, Collombet J M, et al. An araC-controlled bacterial cre expression system to produce DNA minicircle vectors for nuclear and mitochondrial gene therapy. J Biol Chem, 2001, 276(25): 23018-23027.
[6] Jechlinger W, Azimpour T C, Lubitz W, et al. Minicircle DNA immobilized in bacterial ghosts: in vivo production of safe non-viral DNA delivery vehicles. J Mol Microbiol Biotechnol, 2004, 8(4): 222-231.
[7] Chen Z Y, He C Y, Ehrhardt A, et al. Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo. Mol Ther, 2003, 8(3): 495-500.
[8] Tasic B, Hippenmeyer S, Wang C, et al. Site-specific integrase-mediated transgenesis in mice via pronuclear injection. Proc Natl Acad Sci USA, 2011, 108(19): 7902-7907.
[9] Landy A. Dynamic, structural, and regulatory aspects of iambda site-specific recombination. Annual Review of Biochemistry, 1989, 58(1): 913-941.
[10] Liang X, Peng L, Baek C, et al. Single step BP/LR combined gateway reactions. BioTechniques, 2013, 55(5): 265-268.
[11] 刘浏. 位点特异整合型微环DNA在转基因研究中的应用. 上海:上海交通大学, 医学院,2014. Liu L.The Application of Site-specific Integration Minicircle DNA in Transgenic Research.Shanghai:Shanghai Jiao Tong University, Medical School, 2014.
[12] Groth A C, Olivares E C, Thyagarajan B, et al. A phage integrase directs efficient site-specific integration in human cells. Proc Natl Acad Sci USA, 2000, 97(11): 5995-6000.
[13] 刘浏, 周在威, 马晴雯. 位点特异整合型微环DNA的构建及应用. 中国医药生物技术, 2014,9(1): 13-19. Liu L, Zhou Z W, Ma Q W.An improved method to generate site-specific integration minicircle DNA. Chin Med Biotechnol, 2014, 9(1):13-19.
[14] Mayrhofer P, Schleef M, Jechlinger W. Use of minicircle plasmids for gene therapy. Methods Mol Biol, 2009, 542: 87-104.
[15] Darquet A M, Cameron B, Wils P, et al. A new DNA vehicle for nonviral gene delivery: supercoiled minicircle. Gene Ther, 1997, 4(12): 1341-1349.
[16] Nehlsen K, Broll S, Bode J. Replicating minicircles: Generation of nonviral episomes for the efficient modification of dividing cells-research article. Gene Therapy and Molecular Biology, 2006, 10B: 233-243.
[17] Kay M A, He C, Chen Z. A robust system for production of minicircle DNA vectors. Nature Biotechnology, 2010, 28(12): 1287-1296.
[18] Diamantino T, Pereira P, Queiroz J A, et al. Minicircle DNA purification using a CIM(R) DEAE-1 monolithic support. J Sep Sci, 2016, 39(18): 3544-3549.
[19] Chen Z Y, He C Y, Kay M A. Improved production and purification of minicircle DNA vector free of plasmid bacterial sequences and capable of persistent transgene expression in vivo. Hum Gene Ther, 2005, 16(1): 126-131.
[20] Bi Y, Liu X, Zhang L, et al. Pseudo attP sites in favor of transgene integration and expression in cultured porcine cells identified by Streptomyces phage phiC31 integrase. BMC Mol Biol, 2013, 14: 20.
[21] Thyagarajan B, Olivares E C, Hollis R P, et al. Site-specific genomic integration in mammalian cells mediated by phage phiC31 integrase. Mol Cell Biol, 2001, 21(12): 3926-3934.
[22] Chalberg T W, Portlock J L, Olivares E C, et al. Integration specificity of phage phiC31 integrase in the human genome. J Mol Biol, 2006, 357(1): 28-48.
[23] Ortiz-Urda S, Thyagarajan B, Keene D R, et al. Stable nonviral genetic correction of inherited human skin disease. Nat Med, 2002, 8(10): 1166-1170.
[24] Quenneville S P, Chapdelaine P, Rousseau J, et al. Nucleofection of muscle-derived stem cells and myoblasts with phi C31 integrase: Stable expression of a full-length-dystrophin fusion gene by human myoblasts. Molecular Therapy, 2004, 10(4): 679-687.
[25] Jechlinger W. Optimization and delivery of plasmid DNA for vaccination. Expert Rev Vaccines, 2006, 5(6): 803-825.
[26] Pang A S D. Production of antibodies against Bacillus thuringiensis delta-endotoxin by injecting its plasmids. Biochemical and Biophysical Research Communications, 1994, 202(3): 1227-1234.
[27] Woodard L E, Hillman R T, Keravala A, et al. Effect of nuclear localization and hydrodynamic delivery-induced cell division on phiC31 integrase activity. Gene Ther, 2010, 17(2): 217-226.
[28] Ma B G, Duan X Y, Niu J X, et al. Expression of stilbene synthase gene in transgenic tomato using salicylic acid-inducible Cre/loxP recombination system with self-excision of selectable marker. Biotechnol Lett, 2009, 31(1): 163-169. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
